This list is based on the watchlists of people on Stock Events who follow AYAUF. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
The current price of AYAUF is $2.26 USD — it has decreased by -3.05% in the past 24 hours. Watch Artrya stock price performance more closely on the chart.
What is Artrya stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Artrya stocks are traded under the ticker AYAUF.
What is Artrya market cap?▼
Today Artrya has the market capitalization of 357.27M
When is the next Artrya earnings date?▼
Artrya is going to release the next earnings report on August 27, 2026.
What were Artrya earnings last quarter?▼
AYAUF earnings for the last quarter are -0.06 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artrya revenue for the last year?▼
Artrya revenue for the last year amounts to 36,320.83 USD.
What is Artrya net income for the last year?▼
AYAUF net income for the last year is -21.29M USD.